GLP-1 receptor agonists, like Ozempic, Wegovy, Monjauro, Zepbound, semaglutide, and tirzepatide, are commonly used to treat type 2 diabetes (T2D) and support weight loss. These medications help the body manage blood sugar, reduce hunger, and promote fat loss. However, new concerns have emerged about their potential role in muscle loss, also known as sarcopenia—the loss of muscle mass and strength as we age.
1. Rapid Weight Loss and Muscle Reduction
2. Lower Appetite = Less Protein Intake
3. Changes in Muscle Metabolism
4. Increased Fat Burning Over Muscle Preservation
STEP Trials (Semaglutide and Weight Loss)
Diabetes and Muscle Function
Older Adults Are at Higher Risk
1. Strength Training and Resistance Exercise
2. Increase Protein Intake
3. Consider Creatine Supplements
4. Monitor Your Lean Mass
5. Adjust Dosing & Lifestyle for Muscle Preservation
GLP-1 medications are highly effective for weight loss and blood sugar control, but they may also contribute to muscle loss if not used carefully. To protect your muscle strength and metabolism, focus on resistance training, eating enough protein, and monitoring your lean mass. If you’re using GLP-1 therapy, talk to your doctor about ways to preserve muscle while losing weight. More research is needed to fully understand how these medications impact muscle health, but taking proactive steps can help you stay strong and healthy.